Clinical Trials Browser

Solid Tumours × GSK 1363089 × Clear all

NCT00743067 2017-07-26

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours

NCT00742261 2017-07-07

A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumours